Clinical Research Directory
Browse clinical research sites, groups, and studies.
6 clinical studies listed.
Filters:
Tundra lists 6 Chemotherapy Induced Alopecia clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07397325
Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia
Clinical Study of DA-020 as a Treatment for Chemotherapy Induced Alopecia
Gender: FEMALE
Ages: 18 Years - 65 Years
Updated: 2026-04-09
NCT07402330
Pharmacokinetic Study of DA-020
Pharmacokinetic Study of DA-020
Gender: FEMALE
Ages: 18 Years - 55 Years
Updated: 2026-02-12
NCT07033845
Pharmacokinetic Study of Topical Phenylephrine
Pharmacokinetic Study of Topical Phenylephrine
Gender: FEMALE
Ages: 18 Years - 55 Years
Updated: 2025-10-03
NCT07201389
CARE (Chemotherapy Alopecia REduction)
The goal of this research study is to determine if the DigniCap Scalp Cooling System can help prevent chemotherapy-induced hair loss in Black patients.
Gender: FEMALE
Ages: 21 Years - Any
Updated: 2025-10-01
1 state
NCT06762548
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
Clinical Study of DA-007 As a Treatment for Chemotherapy Induced Alopecia
Gender: FEMALE
Ages: 18 Years - 65 Years
Updated: 2025-05-23
NCT06786078
The Lily Device Trial
The goal of this clinical trial is to test if the Lily Device works to reduce chemotherapy induced hair loss in patients. It will also learn about the safety of the Lily Device. The main questions it aims to answer is: * Do patient preserve their hair using the Lily Device after 4 cycles of chemotherapy, when hair preservation is a Grade ≤1 graded by an independent healthcare professional on the Common Terminology Criteria for Adverse Events (CTCAE)? * What is the subject incidence of Grade 1 or above Adverse Device Events (ADE's)?
Gender: All
Ages: 18 Years - Any
Updated: 2025-01-22
3 states